Strong Research Legacy Southern Research’s extensive 80-year history in drug discovery and environmental health demonstrates deep expertise and a proven track record of developing FDA-approved cancer treatments and advancing COVID-19 vaccine research, positioning the organization as a leader in translational science and potential partner for advanced R&D collaborations.

Facility Expansions Recent investments in large-scale biotech facilities in the US and UK, including a $98M biotech center and an $84M biotech campus, highlight significant growth and infrastructure capacity that could facilitate increased contract research, clinical trials, and industry partnerships.

Funding & Grants With recent grants totaling $44M and additional government financing, Southern Research is strengthening its financial foundation to support innovative projects and expand services, which could be leveraged to attract sponsors or collaborators seeking cutting-edge scientific expertise.

Leadership & Talent New high-profile appointments such as COO Harry C. Ledebur Jr. indicate a focus on strategic growth and operational excellence, presenting opportunities to align with leadership on large-scale projects or to offer complementary solutions in research management.

Technological Innovation The organization employs a diverse tech stack including Modernizr, Google Tag Manager, and Module Federation, signaling a commitment to utilizing advanced digital tools and data analytics that can enhance research capabilities and create opportunities for technology partners or providers.